ISSCR News
Stem Cells May Help Identify New Schizophrenia Drugs
In a paper recently published in Stem Cell Reports, researchers followed-up with a screen of 464 drugs and identified a small group of about 20 that reduced C4 secretion from astrocytes. These drugs were effective both in healthy astrocytes & in astrocytes made from Schizophrenia patients’ stem cells.
Member Spotlight: Prisca Liberali, PhD
“One of the most exciting part is the mentoring. Having student that learn and, in the process, become amazing scientist. I am very proud of all my students and I love to put in the best condition possible to achieve their best.”
The ISSCR Urges Appropriations Leaders to Swiftly Pass a Final FY 2023 Labor-HHS-Education Spending Bill
The ISSCR joined with 283 members of the Ad Hoc Group for Medical Research to urge U.S. House and Senate members to swiftly finalize a fiscal year (FY) 2023 spending package that prioritizes robust investments in agencies and programs that improve the nation’s health and well-being, including funding for the National Institutes of Health (NIH).
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .